News

Events

Full Agenda of WuXi Global Forum 2020

2020/01/13

Now in its eighth year, WuXi Global Forum 2020 will continue to bring together thousands of leaders to promote new thinking on a global stage as we strive to provide transformative solutions for patients.


In order to accommodate the growing number of attendees, the WuXi Global Forum 2020 will take place on Jan 14 at the Hilton San Francisco Union Square and feature an expanded program from 1:00 – 7:00 PM PST.


This invitation-only and complimentary event is brought to you by WuXi AppTec, BayHelix, BioCentury, Biocom, BioWorld, ChinaBio, Children's Tumor Foundation, CLSA, Endpoints News, Fiercebiotech, Informa, MassBio, MBC BioLabs and UK BioIndustry Association.



AGENDA


1:00 – 1:30    

REGISTRATION and NETWORKING


1:30 – 1:35

WELCOME

Hui Cai, Forum Chair, VP and Head of Content Division, WuXi AppTec


1:35 – 1:45    

OPENING REMAKRS

Ge Li, Chairman, WuXi AppTec and WuXi Biologics


SESSION I    STATE OF INNOVATION



1:45 – 2:30    

Are We Breaking New Ground?

David Schenkein, General Partner, GV

Antoine Papiernik, Managing Partner, Sofinnova Partners

Kristiina Vuori, President, Sanford Burnham Prebys Medical Discovery Institute

Edward Hu, Co-CEO, WuXi AppTec

Moderated by Eric Elenko, Chief Innovation Officer, PureTech Health


2:30 – 2:50    

A Dialogue with Howard “Skip” Burris, President, ASCO; President of Clinical Operations and CMO, Sarah Cannon

Moderated by Fred Hausheer, Global Chief Medical Officer and Head of WuXi Oncology, WuXi AppTec

 

SESSION II   SPOTLIGHT ON CELL AND GENE THERAPIES



2:50 – 3:20    

Cell Therapies: Where Are We Heading?

Richard Klausner, Founder and CEO, Lyell Immunopharma

Patrick Hwu, Head, Division of Cancer Medicine, MD Anderson Cancer Center

Moderated by Karen Bernstein, Co-Founder and Chairman, BioCentury


3:20 – 3:50    

Delivering the Promise of Gene Therapies

James Wilson, Professor of Medicine and Pediatrics of Department of Medicine and Director of Gene Therapy Program, University of Pennsylvania

Tachi Yamada, Venture Partner, Frazier Healthcare Partners

Moderated by John Carroll, Editor and Founder, Endpoints News

 

SESSION III  RACE TO THE CURE

 


3:50 – 4:10 

A Dialogue with David Liu, Director of the Merkin Institute and Vice-Chair of the Faculty, Broad Institute; Professor of Harvard University and HHMI

Moderated by Chris Chen, CEO, WuXi Biologics


4:10 – 4:55    

Incremental or Transformative?

Paul-Peter Tak, President and CEO, Kintai Therapeutics

Steve Paul, Chairman and CEO, Karuna Therapeutics

Samantha Du, Chairman and CEO, Zai Lab

Lalo Flores, CEO, Century Therapeutics

Moderated by Steve Yang, EVP and CBO, WuXi AppTec

 

SESSION IV INNOVATION 2030



4:55 – 5:15    

A Dialogue with Hans Bishop, CEO, GRAIL

Moderated by Melinda Richter, Global Head, Johnson & Johnson Innovation, JLABS


5:15 – 6:00    

How is Technology Shaping the Future of Healthcare?

Jason Coloma, President and CEO, Maze Therapeutics

Zavain Dar, Partner, Lux Capital

Carolyn Magill, CEO, Aetion

John Halamka, President, Mayo Clinic Platform

Leon Wang, Executive VP International and China President, AstraZeneca

Moderated by Kenneth Kaitin, Professor and Director, Tufts Center for the Study of Drug Development, Tufts University School of Medicine


6:00 – 6:10    

CLOSING REMARKS

Steve Bates, CEO, UK BioIndustry Association


6:10 – 7:00    

RECEPTION

Back